Conference Coverage (NCVDG)

Candidate AIDS Vaccine Combines Common Cold Virus and HIV

Published in Gene Therapy Weekly, June 9th, 1997

Several rhinovirus/HIV chimeric viruses induce high titers of neutralizing antibodies in animal studies.

Two of these chimeras currently are being tested in chimpanzees, according to Gail Ferstandig Arnold and colleagues of Rutgers University, Piscataway, New Jersey.

Arnold reported the development of the candidate HIV vaccine in a poster presentation to the 9th Annual Meeting of the National Cooperative Vaccine Development Groups for AIDS (NCVDG), held May 4-7, 1997, in Bethesda, Maryland.

"Seven of eight chimeric viruses used to immunize guinea pigs were able to elicit neutralizing antibody responses against the MN and ALA-1...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (1997-06-09)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry